Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
BMJ (Clinical Research Ed.)|April 29, 2024
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort studyBjörn Pasternak, Viktor Wintzell, Anders Hviid, et al.
The Lancet. Diabetes & Endocrinology|December 12, 2018
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and SwedenHenrik Svanström, Peter Ueda, Mads Melbye, et al.
BMJ (Clinical Research Ed.)|November 16, 2018
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort studyPeter Ueda, Henrik Svanström, Mads Melbye, et al.
Annals of Neurology|July 3, 2014
Neonatal vitamin D status and risk of multiple sclerosisPeter Ueda, Farshid Rafatnia, Maria Bäärnhielm, et al.
Sexually Transmitted Infections|April 23, 2022
Recent changes in the reporting of STIs in Japan during the COVID-19 pandemicCyrus Ghaznavi, Yuta Tanoue, Takayuki Kawashima, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort StudyPeter Ueda, Viktor Wintzell, Mads Melbye, et al.
Diabetes Care|December 12, 2022
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort StudyArvid Engström, Viktor Wintzell, Mads Melbye, et al.
Hepatology (Baltimore, Md.)|December 12, 2023
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort studyArvid Engström, Viktor Wintzell, Mads Melbye, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 13, 2017
Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross-sectional study in UgandaSamson Okello, Peter Ueda, Michael Kanyesigye, et al.
Pageof 9